Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence rev ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Nerve cells carry an electrical signal from the site of tissue damage up to the brain, which perceives the signal as pain. Unlike opioid medications, which dull the sensation of pain in the brain ...

Watch out for the below potential side effects of steroids in dogs: Nerve pain medications aren't prescribed very often for dogs. But they could help, especially if other medicines don't work for ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...